What is the recommended treatment plan for an infant with eczema?

Recommended Treatment Plan for Infant Eczema

For infants with eczema, initiate a stepwise approach starting with regular emollients as the foundation, followed by low-potency topical corticosteroids for flare-ups, with escalation to topical calcineurin inhibitors or wet-wrap therapy if conventional treatment fails. 1

Foundational Therapy (All Infants)

Emollients and Skin Care

• Apply emollients liberally and frequently (minimum twice daily, ideally after bathing) to maintain skin barrier integrity 1
• Regular emollients provide both short- and long-term steroid-sparing effects 1
• Avoid known irritants: detergents, excessive sweating, saliva, harsh soaps 2, 1

Bathing Practices

• Use lukewarm water with gentle cleansers
• Pat skin dry and immediately apply emollients within 3 minutes 1

Stepwise Anti-Inflammatory Treatment

Mild Eczema

First-line: Low to medium-potency topical corticosteroids (TCS) applied reactively to inflamed areas 1

• Use the lowest effective potency for infants due to increased risk of adrenal suppression 1
• Limit high-potency steroids on face, neck, and skin folds to prevent atrophy 1

Alternative: Pimecrolimus cream 1% (approved for infants ≥3 months in some regions) or crisaborole ointment 1

Moderate Eczema

Preferred approach: Low to medium-potency TCS with proactive maintenance therapy 1

• Clearance phase: Apply TCS once or twice daily for 1-4 weeks to gain control 2
• Maintenance phase: Apply TCS or topical calcineurin inhibitor (TCI) 2-3 times weekly to previously affected areas to prevent relapses 1

Alternative options:

• Tacrolimus 0.03% ointment (age ≥2 years) 1
• Topical PDE-4 inhibitors like crisaborole (age ≥3 months where approved) 1

Severe/Refractory Eczema

Second-line intervention: Wet-wrap therapy with TCS 1

• Apply TCS to affected areas, cover with wet layer, then dry layer
• Duration: 3-7 days, maximum 14 days in severe cases 1
• This is highly effective before considering systemic therapy 2, 1

Important caveat: Wet-wrap therapy increases trans-epidermal penetration of steroids, so use appropriate potency and monitor closely 1

Adjunctive Measures

Infection Management

• Treat bacterial superinfection (usually Staphylococcus aureus) with systemic antibiotics only when clinical signs present 2, 1
• Avoid long-term topical antibiotics due to resistance and sensitization risk 1
• Consider intranasal mupirocin or dilute bleach baths for recurrent infections 1

Pruritus Control

• Oral antihistamines as adjuvant therapy for itch reduction 1
• Avoid topical antihistamines due to insufficient evidence and contact dermatitis risk 1

Critical Pitfalls to Avoid

What NOT to Do

1. Never use long-term oral corticosteroids - unfavorable risk-benefit profile with rebound flares upon discontinuation 1
2. Avoid potent TCS on face/neck/folds in infants - high risk of skin atrophy and systemic absorption 1
3. Do not use topical antibiotics long-term - promotes resistance 1
4. Avoid phototherapy in children <12 years - unclear long-term safety 1

When to Escalate

Consider systemic therapy (cyclosporine, methotrexate, azathioprine, or biologics like dupilumab for age ≥6 months) only after: 2, 1, 3

• Adequate trial of intensive topical therapy (medium to high-potency TCS for 1-4 weeks)
• Comprehensive patient education provided
• Wet-wrap therapy attempted
• Significant impact on quality of life persists

Education Requirements

Essential counseling points for caregivers: 2, 1

• Demonstrate proper emollient application technique
• Address topical steroid phobia with evidence-based reassurance
• Explain trigger avoidance (irritants, allergens, stress)
• Emphasize treatment adherence
• Provide written action plan for flare management

The most recent high-quality evidence (2026 AAD guidelines) strongly recommends moisturizers, topical corticosteroids, and topical calcineurin inhibitors as foundational treatments, with newer agents like dupilumab, JAK inhibitors, and biologics reserved for moderate-to-severe cases in appropriate age groups. 3 However, for typical infant eczema, the stepwise approach outlined above using emollients and low-potency TCS remains the evidence-based standard of care.